Schering-Plough Reports Financial Results for 2009 Third Quarter
Focus and Execution on Core Strategies Drive Solid Performance; 3 of '5 Stars' in Product Pipeline Launched in Major Markets KENILWORTH, N.J., Oct. 22 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE:SGP) today...
News & Articles (Drugs.com) · More like this

Schering-Plough Reports Financial Results for First Quarter of 2007
Company Sustains Momentum into First Quarter of 2007, Moves Ahead on Planned Organon BioSciences Acquisition KENILWORTH, N.J., April 19, 2007 /PRNewswire-FirstCall/ -- Schering-Plough Corporation...
News & Articles (Drugs.com) · More like this

Schering-Plough Reports Financial Results for 2006 Fourth Quarter, Full Year
...full year. 'We registered strong performance both for the recent quarter and for 2006,' said Fred Hassan, chairman and CEO. 'After three full years of progress under the Action Agenda, Schering-Plough is doing what we set out to do -- deliver a solid record of performance while continuing an extraordinary...
News & Articles (Drugs.com) · More like this

Schering-Plough Reports Financial Results for First Quarter of 2008
...KENILWORTH, N.J., April 23, 2008 /PRNewswire-FirstCall/ -- Schering-Plough Corporation today reported financial results for the first quarter of 2008, reviewed progress on its ongoing integration of Organon BioSciences N.V. (OBS) (acquired in November 2007) and addressed recent events affecting...
News & Articles (Drugs.com) · More like this

Schering-Plough Reports Financial Results for Third Quarter of 2007
Solid Performance Continues in Third Quarter of 2007; Company Prepares for Integration of Organon BioSciences KENILWORTH, N.J., October 22, 2007 /PRNewswire-FirstCall/ -- Schering-Plough Corporation...
News & Articles (Drugs.com) · More like this